Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MESD pseudogene 1 (MESDP1) is classified as a pseudogene, meaning it is a DNA sequence that resembles the functional MESD (mesoderm development LRP chaperone) gene but is generally nonfunctional due to accumulated mutations, truncations, or lack of regulatory elements[6][2][5]. Pseudogenes like MESDP1 do not encode functional proteins and are not considered canonical drug or therapeutic targets; however, some pseudogenes in general may exert regulatory effects via competing endogenous RNA (ceRNA) activity, acting as miRNA decoys, or impacting epigenetic regulation, although no such function is specifically known or validated for MESDP1[2][5][6]. There is no evidence that MESD pseudogene 1 is associated with any therapeutic drugs, mechanisms of action, or clinical biomarkers. In summary, MESD pseudogene 1 is not a therapeutic target but is a nonfunctional genomic sequence related to mesoderm development genes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MESD pseudogene 1 (MESDP1).